Cyteir Therapeutics, Inc.
Total raised
$112 M
4 rounds on record
Latest round
$80 M
Feb 2021
First round on record
Oct 2015
Today
Private
No later event on record
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Cyteir Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2021).
SEC Form D · Feb 2021
The industry group it chose in its notices: Other Health Care.
SEC Form D · Feb 2021
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
8 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| DF II GP Sarl | Other | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Ihl SA | Company | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Novo Holdings A/s | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Timothy Romberger | Person | not stated | not stated | Held Series A and B preferred stock, director (Form 3, 2021) | SEC Form 3 |
| Venrock Associates VII, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Venrock Management VII, LLC | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Venrock Partners VII, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Wepaven BV | Other | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Andrew S. Gengos | Executive officer | Feb 2021 |
| Markus Renschler | Executive officer | Feb 2021 |
| Paul S. Secrist | Executive officer | Feb 2021 |
| Timothy Romberger | Executive officer | Oct 2019 |
| Ronald Goldstein | Executive officer | May 2018 |
| Donald Corcoran | Executive officer | Nov 2016 |
| Kevin Mills | Executive officer | Nov 2016 |
| William B. Asher, Jr. | Executive officer | Dec 2015 |
| Janwillem Naesens | Director | Feb 2021 |
| Jean George | Director | Feb 2021 |
| Joseph S. Zakrzewski | Director | Feb 2021 |
| Karen Hong | Director | Feb 2021 |
| Markus Renschler | Director | Feb 2021 |
| Racquel Bracken | Director | Feb 2021 |
| Susan S. Molineaux | Director | Feb 2021 |
| Timothy S. Romberger | Director | Feb 2021 |
| Timothy Romberger | Director | Oct 2019 |
| Bart Van Hooland | Director | May 2018 |
| Barry Mills | Director | Nov 2016 |
| Donald Corcoran | Director | Nov 2016 |
| Kevin Mills | Director | Nov 2016 |
| Barry B. Mills | Director | Dec 2015 |
| Timothy B. Romberger | Director | Dec 2015 |